What companies are MBX's competitors?

MBX Biosciences, Inc. Common Stock (MBX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does MBX compare to its peers?

The peer comparison table on this page shows MBX Biosciences, Inc. Common Stock (MBX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does MBX operate in?

MBX Biosciences, Inc. Common Stock (MBX) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

MBX

MBX Biosciences, Inc. Common Stock

NASDAQ·Biotechnology · Healthcare

$50.46$3.47−6.43%

After hours·$50.46+0.00%

Market cap$2.43B·Market closed·Oct 22 4:00 PM EDT

Frequently Asked Questions About MBX

What companies are MBX's competitors?: MBX Biosciences, Inc. Common Stock (MBX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does MBX compare to its peers?: The peer comparison table on this page shows MBX Biosciences, Inc. Common Stock (MBX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does MBX operate in?: MBX Biosciences, Inc. Common Stock (MBX) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

MBX

MBX Biosciences, Inc. Common Stock

NASDAQ·Biotechnology · Healthcare

$50.46$3.47−6.43%

After hours·$50.46+0.00%

Market cap$2.43B·Market closed·Oct 22 4:00 PM EDT

Peers

Sort:


ASNDASNDAscendis Pharma A/S	Ascendis Pharma A/S	$242.99	$15.2B
RYTMRYTMRhythm Pharmaceuticals, Inc.	Rhythm Pharmaceuticals, Inc.	$90.90	$6.3B
VKTXVKTXViking Therapeutics, Inc.	Viking Therapeutics, Inc.	$25.83	$3.3B
XERSXERSXeris Biopharma Holdings, Inc.	Xeris Biopharma Holdings, Inc.	$10.79	$2.0B
KLRAKLRAKailera Therapeutics, Inc.	Kailera Therapeutics, Inc.	$13.27	$1.7B
ALTALTAltimmune, Inc.	Altimmune, Inc.	$2.17	$422.1M
ORMPORMPOramed Pharmaceuticals Inc.	Oramed Pharmaceuticals Inc.	$4.12	$171.4M
BMEABMEABiomea Fusion, Inc.	Biomea Fusion, Inc.	$0.69	$49.9M
LPCNLPCNLipocine Inc.	Lipocine Inc.	$1.46	$12.0M
SKYESKYESkye Bioscience, Inc.	Skye Bioscience, Inc.	$1.62	$7.2M

Frequently Asked Questions About MBX

What companies are MBX's competitors?: MBX Biosciences, Inc. Common Stock (MBX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does MBX compare to its peers?: The peer comparison table on this page shows MBX Biosciences, Inc. Common Stock (MBX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does MBX operate in?: MBX Biosciences, Inc. Common Stock (MBX) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.